Biotech · Private company
Merz Therapeutics GmbH
Track this companyFree. Adds Merz Therapeutics GmbH to your Dealase workspace and tells you when its record changes.
Clinical trials32 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- XeominPhase 3 · Chronic MigraineClinicalTrials.gov · fetched Nov 12, 2026
- XeominPhase 3 · Episodic MigraineClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Retrospective Chart Abstraction to Investigate the Prevalence of Chronic Sialorrhea, and the Real-world Use of incobotulinumtoxinA Injections in Male and Female Participants Aged 18 Years and Older With Chronic SialorrheaCOMPLETED · started Oct 10, 2025ClinicalTrials.gov NCT07881497 · fetched Nov 12, 2026
- A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic MigrainePHASE3 · ACTIVE_NOT_RECRUITING · started Aug 21, 2025ClinicalTrials.gov NCT07018700 · fetched Nov 12, 2026
- A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic MigrainePHASE3 · ACTIVE_NOT_RECRUITING · started Aug 21, 2025ClinicalTrials.gov NCT07018713 · fetched Nov 12, 2026